Kenneth Dill

Mr. Dill is the CEO and Chairman of Wellesley Pharmaceuticals. A graduate of Brown University, he worked for emerging companies in high-tech, and real estate management during a successful 20 year career. He assumed the reigns of Wesllesley Pharmaceuticas upon the death of his brother David. His focus has been capital raising, building strategic alliances, updating the strategy, and redirecting the team. The original vision still drives the strategic intent of the Company.